Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

BACKGROUND: Although SARS-CoV-2 vaccines immunogenicity in patients with cancer has been investigated, whether they can significantly improve the severity of COVID-19 in this specific population is undefined. METHODS: Capitalizing on OnCovid (NCT04393974) registry data we reported COVID-19 mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinato, David J., Ferrante, Daniela, Aguilar-Company, Juan, Bower, Mark, Salazar, Ramon, Mirallas, Oriol, Sureda, Anna, Bertuzzi, Alexia, Brunet, Joan, Lambertini, Matteo, Maluquer, Clara, Pedrazzoli, Paolo, Biello, Federica, Lee, Alvin J.X., Sng, Christopher C.T., Liñan, Raquel, Rossi, Sabrina, Carmona-García, M.Carmen, Sharkey, Rachel, Eremiev, Simeon, Rizzo, Gianpiero, Bain, Hamish DC., Yu, Tamara, Cruz, Claudia A., Perachino, Marta, Saoudi-Gonzalez, Nadia, Fort-Culillas, Roser, Doonga, Kris, Fox, Laura, Roldán, Elisa, Zoratto, Federica, Gaidano, Gianluca, Ruiz-Camps, Isabel, Bruna, Riccardo, Patriarca, Andrea, Shawe-Taylor, Marianne, Fusco, Vittorio, Martinez-Vila, Clara, Berardi, Rossana, Filetti, Marco, Mazzoni, Francesca, Santoro, Armando, Delfanti, Sara, Parisi, Alessandro, Queirolo, Paola, Aujayeb, Avinash, Rimassa, Lorenza, Prat, Aleix, Tabernero, Josep, Gennari, Alessandra, Cortellini, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124924/
https://www.ncbi.nlm.nih.gov/pubmed/35704976
http://dx.doi.org/10.1016/j.ejca.2022.04.036

Ejemplares similares

Ejemplares similares